← Back to Patent Explorer
US5505726A Expired / Lapsed US ⏱️ 0.0 years remaining

Article of manufacture for the photodynamic therapy of dermal lesion

Assignee: Dusa Pharmaceuticals Inc
•
Filing: 1994-03-21
•
Granted: 1996-04-09
•
Expires: 2014-03-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An article of manufacture for photodynamic therapy of a dermal lesion located at a dermal treatment site on skin including the stratum corneum, transparent hydrogel for covering the dermal treatment site and containing hydration agent and photopharmaceutical, the transparent hydrogel couples the hydration agent to the stratum corneum to hydrate and soften the stratum corneum to enhance its optical transmissiveness to facilitate the transmission of light therethrough and to enhance its chemical transmissiveness to facilitate the transmission therethrough of the photopharmaceutical for treatment of the dermal lesion; and light delivery means are included for delivering light through the transparent hydrogel and the hydrated stratum corneum to photoactivate the photopharmaceutical to treat the dermal lesion.

Inventors

  • 👤 Peter M. Meserol

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 14:03
CPC Classifications
A; A61; A61M; A61M37/00; A61F; A61F13/00; A61F13/02; A61F13/0203; A61F13/0213; A61F13/0226; A61K; A61K9/00; A61K9/0002; A61K9/0009; A61N; A61N5/00; A61N5/06; A61N5/0613; A61N5/062; A61F2013/00361; A61F2013/00365; A61F2013/00655; A61F2013/00676; A61F2013/00846; A61F2013/00902; A61N2005/0635; A61N2005/0643; A61N2005/0645

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 138 words
An article of manufacture for photodynamic therapy of a dermal lesion located at a dermal treatment site on skin which skin includes the stratum corneum, comprising: cover means adapted for being sealed to the skin for covering and defining a dermal treatment site and for providing a chamber opposite the dermal treatment site; transparent transport means containing hydration agent and at least one photopharmaceutical, said transport means residing in said chamber and for engaging the skin at the treatment site to cause said hydration agent to hydrate the stratum corneum at the dermal treatment site to enhance the passage therethrough of light and said photopharmaceutical; and light delivery means mounted to and inside said cover and residing in said chamber for photoactivating said photopharmaceutical at said dermal treatment site to cause said photopharmaceutical to treat the dermal lesion.
Claim 2
Dependent Claim 138 words
An article of manufacture for photodynamic therapy of a dermal lesion located at a dermal treatment site on skin which skin includes the stratum corneum, comprising: cover means adapted for being sealed to the skin for covering and defining a dermal treatment site and for providing a chamber opposite the dermal treatment site; transparent transport means containing hydration agent and at least one photopharmaceutical, said transport means residing in said chamber and for engaging the skin at the treatment site to cause said hydration agent to hydrate the stratum corneum at the dermal treatment site to enhance the passage therethrough of light and said photopharmaceutical; and light delivery means mounted to and inside said cover and residing in said chamber for photoactivating said photopharmaceutical at said dermal treatment site to cause said photopharmaceutical to treat the dermal lesion.
Claim 3
Dependent Claim 22 words
The article according to claim 1 wherein said transparent transport means comprise transparent hydrogel including a water matrix comprising said hydration agent.
Claim 4
Dependent Claim 41 words
The article according to claim 1 wherein said light delivery means comprise a fiber optic laser light emitting panel comprising a plurality of optical fibers provided with side openings for the lateral transmission of laser light therethrough to photoactivate said photopharmaceutical.
Claim 5
Dependent Claim 45 words
The article according to claim 3 wherein said cover means includes an internal surface defining said chamber and wherein said cover means further comprises a reflective layer provided on said internal surface for reflecting said laser light through said transparent hydrogel and to said photopharmaceutical.
Claim 6
Dependent Claim 30 words
The article according to claim 4, wherein said photopharmaceutical is photoactivated at a predetermined wavelength and wherein said fiber optic laser light-emitting panel provides monochromatic light at said predetermined wavelength.
Claim 7
Dependent Claim 13 words
The article according to claim 5 wherein said predetermined wavelength is 635 nm.
Claim 8
Dependent Claim 53 words
The article according to claim 1 wherein said cover means includes a lower portion provided with an outwardly extending peripheral portion circumscribing said lower portion and a layer of adhesive applied to said peripheral portion for sealingly engaging the skin to seal said cover means to the skin over said dermal treatment site.
Claim 9
Dependent Claim 104 words
The article according to claim 1 wherein said transport means comprise a first layer of transparent hydrogel received in said chamber and a second layer of transparent hydrogel received in said chamber and for residing intermediate said first layer of hydrogel and the dermal treatment site, said first layer of hydrogel including a water matrix providing said hydration agent and said second layer of hydrogel being smaller in size than said first layer and generally shaped to cover only the dermal lesion located at the dermal treatment site, and said second layer of hydrogel including a water matrix into which said photopharmaceutical is absorbed.
Claim 10
Dependent Claim 191 words
An article of manufacture for photodynamic therapy of a dermal lesion located at a dermal treatment site on skin which skin includes the stratum corneum, comprising: cover means adapted for being sealed to the skin for covering and defining a dermal treatment site and for providing a chamber opposite the dermal treatment site; transparent coupling means contained in said chamber and for covering the dermal treatment site, said transparent coupling means containing at least one hydration agent and at least one photopharmaceutical, said transparent coupling means for coupling said hydration agent to the stratum corneum at the dermal treatment site to hydrate and soften the stratum corneum to enhance the optical transmissiveness of the stratum corneum to facilitate the transmission of light therethrough and to enhance its chemical transmissiveness to facilitate the transmission therethrough of said photopharmaceutical for treatment of the dermal lesion; and light delivery means mounted to and inside said cover and for delivering light through said transparent coupling means and through said hydrated stratum corneum to illuminate the dermal treatment site by light diffusion to photoactivate said photopharmaceutical at said dermal treatment site to treat the dermal lesion.
Claim 11
Dependent Claim 191 words
An article of manufacture for photodynamic therapy of a dermal lesion located at a dermal treatment site on skin which skin includes the stratum corneum, comprising: cover means adapted for being sealed to the skin for covering and defining a dermal treatment site and for providing a chamber opposite the dermal treatment site; transparent coupling means contained in said chamber and for covering the dermal treatment site, said transparent coupling means containing at least one hydration agent and at least one photopharmaceutical, said transparent coupling means for coupling said hydration agent to the stratum corneum at the dermal treatment site to hydrate and soften the stratum corneum to enhance the optical transmissiveness of the stratum corneum to facilitate the transmission of light therethrough and to enhance its chemical transmissiveness to facilitate the transmission therethrough of said photopharmaceutical for treatment of the dermal lesion; and light delivery means mounted to and inside said cover and for delivering light through said transparent coupling means and through said hydrated stratum corneum to illuminate the dermal treatment site by light diffusion to photoactivate said photopharmaceutical at said dermal treatment site to treat the dermal lesion.

References Cited (Backward Citations)

US4886831A Cited
WO1988007841A1 Cited
US5039491A Cited
US5300097A Cited
US5445608A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-04-09 1999-10-09 2000-04-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-04-09 2003-10-09 2004-04-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-04-09 2007-10-09 2008-04-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag